Philippines Health News API

{
    "totalArticles": 100372,
    "articles": [
        {
            "id": "cd7c7fa3cc4f55d3c04cb805c95b2183",
            "title": "Buck Institute Launches Healthspan Horizons to Make Long-Term Health Measurable and Actionable",
            "description": "New federated research platform links real-world data with aging science to extend healthy years of life",
            "content": "New federated research platform links real-world data with aging science to extend healthy years of life\nNOVATO, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- The Buck Institute for Research on Aging today announced the launch of Healthspan Horizons, a ... [3606 chars]",
            "url": "https://www.manilatimes.net/2026/03/06/tmt-newswire/globenewswire/buck-institute-launches-healthspan-horizons-to-make-long-term-health-measurable-and-actionable/2294387",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/03/06/962176.jpg",
            "publishedAt": "2026-03-05T19:09:58Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "9aea17c319e345cd1de3b7ea45f48492",
            "title": "Cerecin Announces TEDx Talk by CEO Dr. Charles Stacey is Now Available Online",
            "description": "**media[961896]**Titled 'The Potential of Fasting and Diet in the Future of Medicine'",
            "content": "Titled \"The Potential of Fasting and Diet in the Future of Medicine\"\nHighlighting the Potential of Ketones - from Fasting, the Ketogenic diet and Pharmaceuticals - to Address Neurological Disease and Improve Brain Health\nDENVER, Colo., March 5, 2026 ... [5314 chars]",
            "url": "https://www.manilatimes.net/2026/03/05/tmt-newswire/pr-newswire/cerecin-announces-tedx-talk-by-ceo-dr-charles-stacey-is-now-available-online/2294203",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/03/05/961894.jpg",
            "publishedAt": "2026-03-05T14:48:07Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "40e1c5bce72f6da918052867581a697e",
            "title": "Priavoid to Present Initial Phase 2 Safety Data for Alzheimer‘s and Preclinical PoC for Parkinson‘s Programs at AD/PD™ 2026",
            "description": "Dusseldorf, Germany, March 5, 2026 - Priavoid GmbH ('Priavoid”) today announced it will present promising initial safety data from the ongoing Phase 2 trial (PRImus-AD, NCT06182085) evaluating its lead candidate PRI-002 in Alzheimer’s disease (AD), as well as preclinical proof-of-concept data for its candidate PRI-101 in alpha-synucleinopathy models like Parkinson’s disease (PD) at the upcoming AD/PD™ 2026 International Conference, taking place from March 17-21, 2026 in Copenhagen, Denmark. Both candidates are based on Priavoid’s proprietary development platform and represent a novel class of orally available all-d-peptide therapeutics designed to detangle neurotoxic oligomer species to inhibit and reverse disease-specific protein aggregation in neurodegenerative disorders.",
            "content": "Dusseldorf, Germany, March 5, 2026 - Priavoid GmbH (\"Priavoid”) today announced it will present promising initial safety data from the ongoing Phase 2 trial (PRImus-AD, NCT06182085) evaluating its lead candidate PRI-002 in Alzheimer’s disease (AD), a... [3143 chars]",
            "url": "https://www.manilatimes.net/2026/03/05/tmt-newswire/globenewswire/priavoid-to-present-initial-phase-2-safety-data-for-alzheimers-and-preclinical-poc-for-parkinsons-programs-at-adpd-2026/2293799",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/03/05/961203.png",
            "publishedAt": "2026-03-05T10:12:32Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        }
    ]
}